)
Edge11 Sep 2026
Texas Pacific Land Corporation: Keeper of the Permian Basin
Land once granted to a failed 19th-century railroad now generates royalties for Texas Pacific Land Corporation across the Permian Basin.
Perpetua Medical
Perpetua Medical (PERP) investor relations material
Perpetua Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary21 Aug, 2026
Executive summary
Net sales for Q2 2026 rose 121% year-over-year to 5,963 KSEK, driven by the Spirotronic acquisition and growth at ES Medical.
Operating loss widened to -3,095 KSEK in Q2 2026 from -538 KSEK a year earlier, mainly due to higher expenses from acquisitions and product development.
Cash and cash equivalents at quarter-end were 16,828 KSEK, up from 5,989 KSEK last year.
The company is actively pursuing further acquisitions and developing proprietary products in its subsidiaries.
Financial highlights
Q2 2026 net revenue: 5,963 KSEK (Q2 2025: 2,700 KSEK); H1 2026 net sales: 10,943 KSEK (H1 2025: 5,927 KSEK).
Q2 2026 operating loss: -3,095 KSEK (Q2 2025: -538 KSEK); H1 2026 operating loss: -5,861 KSEK (H1 2025: -1,972 KSEK).
Q2 2026 EPS: -0.36 SEK (Q2 2025: -0.16 SEK); H1 2026 EPS: -0.69 SEK (H1 2025: -0.44 SEK).
Q2 2026 cash flow: -3,456 KSEK (Q2 2025: -1,224 KSEK); H1 2026 cash flow: 12,495 KSEK (H1 2025: -3,411 KSEK).
Equity at 30 June 2026: 25,467 KSEK (30 June 2025: 8,912 KSEK); equity ratio: 44% (55%).
Outlook and guidance
Management expects further growth through additional acquisitions and proprietary product launches.
Ongoing negotiations with several acquisition targets could result in near-term transactions.
ES Medical is preparing to launch its first proprietary product in H2 2026.
Spirotronic is targeting integration of its components into next-generation ventilators.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Perpetua Medical
- Revenue up 54% year-over-year, but operating loss widened; strong cash supports acquisition focus.PERP
Q1 2026 - Net sales doubled and operating income turned positive, supported by a major capital raise.PERPQ4 2025
- Q3 2025 delivered record revenue and profit, fueled by asset sales and the Spirotronic acquisition.PERPQ3 2025
- Q2 2025 sales up 165%, losses reduced, major acquisition and asset sale boost outlook.PERPQ2 2025
- First acquisition completed, losses reduced, and cost base lowered as strategic shift advances.PERPQ3 2024
- Operating loss narrowed, cash position strengthened, and acquisition strategy advanced.PERPQ2 2024
- Strong sales growth from ES-Medical offset by negative operating result and strategic realignment.PERPQ1 2025
- Q4 revenue jumped 62% on ES-Medical, with improved losses and strong cash flow.PERPQ4 2024
Next Perpetua Medical earnings date
Q3 202620 Nov, 2026
Perpetua Medical
Next Perpetua Medical earnings date
Q3 202620 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage